DOI:
10.1055/s-00000058
Planta Medica
LinksClose Window
References
Kushner P.
Benefits/risks of sodium-glucose co-transporter 2 inhibitor canagliflozin in women for the treatment of type 2 diabetes.
Womenʼs Health (Lond) 2016;
12: 379-388
Access:
We do not assume any responsibility for the contents of the web pages of other providers.